How to evidence a moat when margins and ROIC don't apply, how to read leverage in a project-financed holding, and how to net a long risk register down to a decision.
1. When margin metrics don't apply, evidence the moat with franchise growth and duration
The repeatable method
- State plainly which standard metrics fail and why (no product sold → no meaningful gross margin; capital spread across funds → no measurable invested capital).
- Substitute three evidence classes: duration of excess return (decades of returns very few firms achieve), franchise growth (client assets compounding, which is a vote of confidence you can count), and economics of the fee stream (fee-related earnings and their margin).
- Require the fee earnings to grow faster than assets — that shows pricing and operating leverage, not just accumulation.
Here: BN — 19%/yr for 30+ years, AUM CAGR 15.7% since 2012, and FRE CAGR 24.2% over ten years at a 57% margin. "So, Brookfield isn't just managing more money, it's also making more profit from it."
Watch for
- FRE growth decelerating below AUM growth — the first sign that fee rates are being competed down.
2. Rate capital by how long it can stay — permanence is a competitive weapon
The repeatable method
- Ask, for every pool of capital a firm invests, when it must be given back. Fund capital with a 7–10 year life forces selling on a schedule; balance-sheet and insurance capital does not.
- Convert that into an advantage test: can the firm hold a good asset through a bad market, or is it a forced seller at the worst moment?
- Look for the compounding loop this enables — invest own capital, attract outside capital, earn fees, reinvest the profits.
Here: ordinary funds are "temporary houses for money"; Brookfield's permanent capital lets it "hold on to great businesses, improve them, and let their value grow over decades." The COVID office trade is the demonstration — it bought while others sold.
Watch for
- The share of AUM that is perpetual vs fund-life capital — the mix, not the headline AUM, determines who can be patient.
3. Score the counter-cyclical behaviour, not the counter-cyclical talk
The repeatable method
- Find a moment when the firm's asset class was in disgrace, and check what it did with capital then.
- Buying into that dislocation — funded from existing deployable capital rather than emergency equity — is evidence of both temperament and balance-sheet capacity.
- Check the follow-through: did the position work, and is the firm positioned for the recovery it bet on?
Here: "During COVID, many companies sold their office buildings. Brookfield didn't. Instead, it bought more at lower prices" — with office demand recovering and fewer quality buildings available, "Brookfield is in a strong position."
Watch for
- Deployable dry powder before the dislocation — a firm can only be counter-cyclical if it kept the capacity ($159bn here).
4. Read leverage by where it sits, not by the group ratio
The repeatable method
- Split debt into parent-level (recourse to the whole company) and project/subsidiary-level (non-recourse — only that asset is at risk).
- Compute the parent ratio separately from the consolidated one; the consolidated number will overstate group fragility for any project-financed business.
- Quantify the buffer alongside it: cash plus undrawn lines plus long-dated insurance capital — what survives a shut credit market.
Here: 47% debt-to-capitalization group-wide but 21% at the parent, with 94% of debt non-recourse and $159bn deployable. "If that project runs into trouble, only that project's money is at risk, not the whole company."
Watch for
- Recourse guarantees or support agreements that quietly convert non-recourse debt into group risk; and refinancing walls in a rising-rate environment.
5. Write the risk register per division — then net it against the structure
The repeatable method
- List risks division by division rather than as one generic paragraph, so each risk attaches to the cash flow it actually threatens.
- Then ask the offsetting question: when this risk fires, what happens to the other divisions? Real diversification means the legs fail at different times.
- Only claim risk is "managed" where the structure — not management commentary — provides the offset.
Here: operating (complexity, refinancing, dependence on selling), asset management (fundraising cycles, performance, regulation), wealth (market sensitivity, trust, float mismatch), plus climate and cyber firm-wide — netted as "a three-legged stool that can still stand even if one leg wobbles," because base management fees keep accruing when prices fall and the float keeps arriving regardless.
Watch for
- A single macro factor (rates) that hits all three legs at once — that's the correlation the stool metaphor hides.
6. Check the company is in good markets — plural — and name the structural driver of each
The repeatable method
- For every segment, name the multi-decade force behind demand (essential infrastructure, institutional appetite for alternatives, demographics and pension reform).
- Prefer needs over preferences: "these are not luxury items. They are essential parts of modern life."
- Where a technology narrative dominates the headlines, work out whether the company sells into it — the picks-and-shovels position beats the disrupted one.
Here: essential real assets (with AI framed as demand — "AI needs lots of computing power, and that needs electricity, cooling, and space"), alternatives fundraising, and Wealth Solutions on ageing plus the defined-benefit → defined-contribution shift.
Watch for
- A "structural trend" that is really a cyclical one — check whether the driver survives a recession and a rate cycle.
Methods distilled from the archived Compounding Quality post for personal study. Not investment advice.